Search

everythinglearnresearchcommunity

for

Search:↓

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

Antiretrovirals can affect finasteride's effectiveness, so dose adjustments may be needed for men on HIV treatment.

Finasteride reduces some inflammation in BPH but not all.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

The document suggests that drugs for prostate issues might cause lasting sexual, mental, and physical health problems due to blood vessel damage in the penis.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Men with self-diagnosed PFS-related ED have normal erectile hemodynamics.

5-alpha reductase inhibitors like finasteride and dutasteride are effective for treating enlarged prostate and male pattern hair loss.

Both drugs lower DHT levels, with GI198745 being more effective.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Men with better urinary symptoms have a lower risk of death.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Man stopped medications due to sexual side effects, found relief with prostatic artery embolisation.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Some drugs may reduce prostatitis symptoms short-term with few side effects.